These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 15855219)

  • 21. Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: a meta-analysis.
    Ho KM; Morgan DJ
    Anaesth Intensive Care; 2008 Sep; 36(5):646-53. PubMed ID: 18853581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
    Tumlin JA; Wang A; Murray PT; Mathur VS
    Am Heart J; 2002 May; 143(5):894-903. PubMed ID: 12040355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
    Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
    Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
    Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
    Kini AA; Sharma SK
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
    Kurnik BR; Allgren RL; Genter FC; Solomon RJ; Bates ER; Weisberg LS
    Am J Kidney Dis; 1998 Apr; 31(4):674-80. PubMed ID: 9531185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for the prevention of contrast-induced acute kidney injury.
    Weisbord SD; Palevsky PM
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):539-49. PubMed ID: 20625289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients.
    Madyoon H; Croushore L; Weaver D; Mathur V
    Catheter Cardiovasc Interv; 2001 Jul; 53(3):341-5. PubMed ID: 11458411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contrast-induced nephropathy].
    Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
    Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
    van den Berk G; Tonino S; de Fijter C; Smit W; Schultz MJ
    Crit Care; 2005 Aug; 9(4):361-70. PubMed ID: 16137385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
    Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
    Bilasy ME; Oraby MA; Ismail HM; Maklady FA
    J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and nondialytic treatment of acute renal failure.
    Lameire NH; De Vriese AS; Vanholder R
    Curr Opin Crit Care; 2003 Dec; 9(6):481-90. PubMed ID: 14639067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiocontrast-induced acute renal failure: allocations and outcomes.
    Mehran R; Ashby DT
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S9-13. PubMed ID: 12439362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
    Lepor NE
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
    Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW;
    JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
    Baker CS; Wragg A; Kumar S; De Palma R; Baker LR; Knight CJ
    J Am Coll Cardiol; 2003 Jun; 41(12):2114-8. PubMed ID: 12821233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.